Mission Bio
South San Francisco, California, United States · Biotechnology, research · 77 employees
Mission Bio is the single-cell tri-omics leader. The company’s Tapestri Platform is unique in its capabilities, offering an unparalleled level of granularity and precision that is critical for complex research areas such as cancer studies, pharmaceutical development, and advanced cell and gene therapies. Unlike traditional methods, such as bulk sequencing, Tapestri provides a level of precision th
Funding history
- Venture - Series Unknown — Undisclosed — Aug 2025
- Venture - Series Unknown — $28.4M — Jul 2018
Recent signals
- Oct 09, 2025: Mission Bio Appoints Dr. Zivjena Vucetic as Chief Medical Officer
- Aug 05, 2025: Raised funding in Venture - Series Unknown
- Dec 02, 2024: Mission Bio collaborates with University of Miami to advance early relapse detection & treatment selection for Multiple Myeloma patients
- Jan 04, 2024: Mission Bio Appoints Industry Veteran Brian Kim as CEO to Spearhead Single-Cell Genomic Solutions
- Jul 11, 2018: Raised $28.4M in Venture - Series Unknown
See plans & pricing → Track Mission Bio’s funding, hiring, and signals — with verified contacts — on Fundz.